Andrew discusses the pressures pharmaceutical companies are currently facing with respect to Big Data. The explosion of data in recent years has caused serious challenges in the security, analytics and management of sensitive information. This presentation offers an exclusive insight into one of the main issues pharmaceutical companies are attempting to overcome.
Please note: That all fields marked with an asterisk (*) are required.
*Processing your payment may take a moment. Please click submit payment only once, and do not refresh this page. Doing so may result in your credit card being charged more than once.